Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

So-Young International (SY) Common Equity (2017 - 2025)

So-Young International (SY) posted Common Equity of $219.0 million for Q4 2025, down 19.69% on a QoQ basis from $272.7 million in Q4 2024, and down 19.69% year-over-year from $272.7 million in Q4 2024.

So-Young International (SY) has 9 years of Common Equity data on file, last reported at $219.0 million in Q4 2025.

  • In Q4 2025, Common Equity fell 19.69% year-over-year to $219.0 million; the TTM figure through Dec 2025 stood at $219.0 million (down 19.69% YoY), while the FY2025 annual figure was $222.1 million, down 11.84% from the prior year.
  • Common Equity fell to $219.0 million in Q4 2025, from $272.7 million in the prior quarter.
  • Across five years, Common Equity topped out at $393.7 million in Q4 2021 and bottomed at $219.0 million in Q4 2025.
  • A 5-year average of $321.6 million and a median of $355.7 million in 2023 frame the typical range for Common Equity.
  • Annual changes were most pronounced in 2021 — Common Equity advanced 0.49% — and 2024, when it declined 23.35%.
  • Year by year, Common Equity stood at $393.7 million in 2021, then slipped by 6.86% to $366.7 million in 2022, then fell by 2.98% to $355.7 million in 2023, then declined by 23.35% to $272.7 million in 2024, then dropped by 19.69% to $219.0 million in 2025.
  • The last three Common Equity figures came in at $219.0 million (Q4 2025), $272.7 million (Q4 2024), and $355.7 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 7.21 Bn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 1.98 Bn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 2.05 Bn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 111.69 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 950.84 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 3.94 Bn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 814.32 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 753.06 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 1.26 Bn
10 So-Young International 28.43 Mn -78.18 Mn 26.35 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 219.01 Mn
Dec 31, 2024 272.69 Mn
Dec 31, 2023 355.73 Mn
Dec 31, 2022 366.68 Mn
Dec 31, 2021 393.69 Mn
Dec 31, 2020 391.77 Mn
Dec 31, 2019 374.94 Mn
Mar 31, 2019 53.52 Mn
Dec 31, 2018 -51.72 Mn
Dec 31, 2017 -25.24 Mn